TXTM .0009 HUGE FIND~ South Africa Upcoming legali
Post# of 103015
TXTM owns this Plandai Biotechnology South Africa, http://www.plandaibiotech.com/products.html main business simply speaking organic bio Extraction.
Recently South African government granted this company a license for weed - http://www.vervedynamics.co.za/products They are basically Bio Extraction company.
Similarities between TXTM's Plandai and recently granted company is EXTRACTION. License is imminent here my friends. 3rd wave set up 10+ bagger gem.
Recent updates on SA legalization:
https://qz.com/1080156/legalize-weed-lesotho-...a-license/
Now combine first above post to this TXTM dots:
...below quote is from Protext news published Sept 20, 2017 : http://www.marketwired.com/press-release/prot...234373.htm
They are very near imo:
Quote:
On Tuesday of this week, we were notified by the DoH that our application has now moved on to the Narcotic Desk of SAPS (South African Police Service) for police clearance of all applicants to check for suitability in handling cannabis, as per the MCC guidelines published March 2017. The Company is in regular communication with senior government officials at the Ministry of Health and we expect to have the license issued once the final regulations are ratified, which, according to statements from government, should be very soon."
Once they (TXTM) grants license - they are planning to do this below shit (for investor - tons of high profile cannabis updates from SA)
Quote:
Once the license is issued, the company intends to use a 10,000 square foot facility in the Mpumalanga province where plants will be grown, cloned and cultivated to ensure a consistent chemical profile. The facility will incorporate an on-site laboratory which will be designed and engineered to process live plant material and after separation and recovery of the oil-phase as a separate income stream, the final stage will be specific to the production of the Phytofare® complex containing cannabinoids, cannabinoid acids, terpenes, limonene and polyphenols. The resulting complex will be subjected to product profiling, analysis and bioavailability in order to determine efficacy and dosage. The Company will use its proprietary processing and extraction technology to commence investigations and produce a full-profile cannabis extract, one that contains both CBD and the precursor acid form of THC (THC-A and THC- found in live cannabis plants. The Company's investigations will be designed to show that the extraction process, which will use live leaf and low temperatures to extract the phyto-chemicals, should leave the acid forms of THC intact, resulting in a non-psychoactive extract with full medicinal potential and having the heightened bioavailability of other Phytofare® extracts.